Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Robison

Showing results (271-280 of 284) with videos related to

Pageof 29
Sort By:
Pediatric Blood & Cancer|October 15, 2013
A phase II trial of a multi-agent oral antiangiogenic (metronomic) regimen in children with recurrent or progressive cancerNathan J Robison, Federico Campigotto, Susan N Chi, et al.
The Lancet. Oncology|June 6, 2020
Response assessment in paediatric low-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working groupJason Fangusaro, Olaf Witt, Pablo Hernáiz Driever, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 30, 2026
Pediatric Brain Tumor Consortium phase 1 study of CD40 agonist sotigalimab in pediatric and young adult patients with recurrent CNS tumors and newly-diagnosed DIPGHolly B Lindsay, Catherine A Billups, Mehmet Kocak, et al.
Nature Communications|October 26, 2022
Rescue of deficits by Brwd1 copy number restoration in the Ts65Dn mouse model of Down syndromeSasha L Fulton, Wendy Wenderski, Ashley E Lepack, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Discovery of Small Molecules and a Druggable Groove That Regulate DNA Binding and Release of the AP1 Transcription Factor ΔFOSBSean McNeme, Yun Young Yim, Ashwani Kumar, et al.
The Journal of Biological Chemistry|December 24, 2025
Discovery of Small Molecules and a Druggable Groove That Regulate DNA Binding and Release of the AP-1 Transcription Factor ΔFOSBSean McNeme, Yun Young Yim, Ashwani Kumar, et al.
Science Translational Medicine|July 26, 2013
CaMKII is essential for the proasthmatic effects of oxidationPhilip N Sanders, Olha M Koval, Omar A Jaffer, et al.
Neuro-Oncology|May 14, 2024
Resistance, rebound, and recurrence regrowth patterns in pediatric low-grade glioma treated by MAPK inhibition: A modified Delphi approach to build international consensus-based definitions-International Pediatric Low-Grade Glioma CoalitionPatricia O'Hare, Tabitha Cooney, Peter de Blank, et al.
Nature Neuroscience|February 3, 2015
Epigenetic basis of opiate suppression of Bdnf gene expression in the ventral tegmental areaJa Wook Koo, Michelle S Mazei-Robison, Quincey LaPlant, et al.
Neuro-Oncology|May 19, 2026
Tempered Optimism: Advances in the Precision Medicine Era for Pediatric Low-Grade GliomaChelsea Kotch, Sebastien Perreault, Phoebe Power, et al.
Pageof 29

Showing results (271-280 of 284) with videos related to

Sort By:
Pageof 29
Pediatric Blood & Cancer|October 15, 2013
A phase II trial of a multi-agent oral antiangiogenic (metronomic) regimen in children with recurrent or progressive cancerNathan J Robison, Federico Campigotto, Susan N Chi, et al.
The Lancet. Oncology|June 6, 2020
Response assessment in paediatric low-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working groupJason Fangusaro, Olaf Witt, Pablo Hernáiz Driever, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 30, 2026
Pediatric Brain Tumor Consortium phase 1 study of CD40 agonist sotigalimab in pediatric and young adult patients with recurrent CNS tumors and newly-diagnosed DIPGHolly B Lindsay, Catherine A Billups, Mehmet Kocak, et al.
Nature Communications|October 26, 2022
Rescue of deficits by Brwd1 copy number restoration in the Ts65Dn mouse model of Down syndromeSasha L Fulton, Wendy Wenderski, Ashley E Lepack, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Discovery of Small Molecules and a Druggable Groove That Regulate DNA Binding and Release of the AP1 Transcription Factor ΔFOSBSean McNeme, Yun Young Yim, Ashwani Kumar, et al.
The Journal of Biological Chemistry|December 24, 2025
Discovery of Small Molecules and a Druggable Groove That Regulate DNA Binding and Release of the AP-1 Transcription Factor ΔFOSBSean McNeme, Yun Young Yim, Ashwani Kumar, et al.
Science Translational Medicine|July 26, 2013
CaMKII is essential for the proasthmatic effects of oxidationPhilip N Sanders, Olha M Koval, Omar A Jaffer, et al.
Neuro-Oncology|May 14, 2024
Resistance, rebound, and recurrence regrowth patterns in pediatric low-grade glioma treated by MAPK inhibition: A modified Delphi approach to build international consensus-based definitions-International Pediatric Low-Grade Glioma CoalitionPatricia O'Hare, Tabitha Cooney, Peter de Blank, et al.
Nature Neuroscience|February 3, 2015
Epigenetic basis of opiate suppression of Bdnf gene expression in the ventral tegmental areaJa Wook Koo, Michelle S Mazei-Robison, Quincey LaPlant, et al.
Neuro-Oncology|May 19, 2026
Tempered Optimism: Advances in the Precision Medicine Era for Pediatric Low-Grade GliomaChelsea Kotch, Sebastien Perreault, Phoebe Power, et al.
Pageof 29